UK markets open in 4 hours 34 minutes
NIKKEI 225
38,682.46 +446.39 (+1.17%) HANG SENG
18,508.53 -69.77 (-0.38%) CRUDE OIL
78.61 +0.13 (+0.17%) GOLD FUTURES
2,328.50 -2.70 (-0.12%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,796.86 -336.84 (-0.66%)
Sartorius Stedim Biotech S.A. (0RG8.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
At close: 05:37PM BST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 20.03B |
| Enterprise value | 23.60B |
| Trailing P/E | 62.29 |
| Forward P/E | 35.21 |
| PEG ratio (5-yr expected) | 1.39 |
| Price/sales (ttm) | 6.95 |
| Price/book (mrq) | 7.72 |
| Enterprise value/revenue | 8.50 |
| Enterprise value/EBITDA | 31.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.48 |
| 52-week change 3 | -15.01% |
| S&P500 52-week change 3 | 24.49% |
| 52-week high 3 | 287.60 |
| 52-week low 3 | 0.00 |
| 50-day moving average 3 | 247.20 |
| 200-day moving average 3 | 233.71 |
Share statistics
| Avg vol (3-month) 3 | 95.61k |
| Avg vol (10-day) 3 | 99.77k |
| Shares outstanding 5 | 92.16M |
| Implied shares outstanding 6 | 114.27M |
| Float 8 | 24.21M |
| % held by insiders 1 | 73.60% |
| % held by institutions 1 | 13.95% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 1.44 |
| Forward annual dividend yield 4 | 0.78% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 20.87% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 30 Mar 2023 |
| Last split factor 2 | 6:1 |
| Last split date 3 | 06 May 2016 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 15.56% |
| Operating margin (ttm) | 23.22% |
Management effectiveness
| Return on assets (ttm) | 6.58% |
| Return on equity (ttm) | 18.66% |
Income statement
| Revenue (ttm) | 2.96B |
| Revenue per share (ttm) | 32.11 |
| Quarterly revenue growth (yoy) | -24.10% |
| Gross profit (ttm) | 1.83B |
| EBITDA | 879.1M |
| Net income avi to common (ttm) | 460.4M |
| Diluted EPS (ttm) | 6.90 |
| Quarterly earnings growth (yoy) | -87.40% |
Balance sheet
| Total cash (mrq) | 118.7M |
| Total cash per share (mrq) | 1.29 |
| Total debt (mrq) | 3.79B |
| Total debt/equity (mrq) | 144.33% |
| Current ratio (mrq) | 1.79 |
| Book value per share (mrq) | 28.27 |
Cash flow statement
| Operating cash flow (ttm) | 625.3M |
| Levered free cash flow (ttm) | -22.32M |
© 2024 Yahoo. All rights reserved.